Profound Medical (PROF) said Friday that it priced an underwritten public offering of about 4.7 million common shares at $7.50 per share to raise gross proceeds of about $35 million.
The company granted the underwriters a 30-day option to purchase up to an additional 700,005 common shares at the same offering price.
Profound Medical expects to close the offering on or about Tuesday and said proceeds will be used to fund the commercialization of its Tulsa-Pro and Sonalleve systems and for general working capital.
Price: 8.03, Change: -0.16, Percent Change: -1.95
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments